Literature DB >> 24750919

Inclusion complex of methyl-β-cyclodextrin and olanzapine as potential drug delivery system for schizophrenia.

Márcia Rocha de Freitas1, Larissa Araújo Rolim2, Monica Felts de La Roca Soares1, Pedro José Rolim-Neto2, Miracy Muniz de Albuquerque1, José Lamartine Soares-Sobrinho1.   

Abstract

Olanzapine (OLP), the most important atypical antipsychotic drug of the new generation, a high cost drug, has low aqueous solubility, affecting its dissolution and absorption. Its complexation with modified cyclodextrins (CDs) is designed to achieve novel vectorization systems with higher solubility, consequently higher bioavailability. From the CD selection, among β-CD, methyl-β-CD (MβCD) and hydroxypropyl-β-CD, it was obtained a phase solubility diagram suggesting a 1:1 (mol:mol) OLP-CD stoichiometry and complexation constants of 966.9, 149.4 and 91.1 L/mol, respectively. The MβCD was selected for the inclusion complexes (IC) attainment, a physical mixture (PM) and a rotatory evaporator product (ROE). The analysis showed differences in the structure, morphology and performance of OLP, MβCD, PM and ROE, revealing the occurrence of interactions between drug and CD. The ROE presented the higher dissolution efficiency and stability. The results suggest that the IC was formation, being a technological resource efficient and profitable for drug delivery.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 24750919     DOI: 10.1016/j.carbpol.2012.03.072

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  11 in total

1.  Losartan Interactions with 2-Hydroxypropyl-β-CD.

Authors:  Vasiliki Palli; Georgios Leonis; Nikoletta Zoupanou; Nikitas Georgiou; Maria Chountoulesi; Nikolaos Naziris; Demeter Tzeli; Costas Demetzos; Georgia Valsami; Konstantinos D Marousis; Georgios A Spyroulias; Thomas Mavromoustakos
Journal:  Molecules       Date:  2022-04-08       Impact factor: 4.927

2.  New Hybrid Nanomaterial Based on Self-Assembly of Cyclodextrins and Cobalt Prussian Blue Analogue Nanocubes.

Authors:  Caio L C Carvalho; Anna T B Silva; Lucyano J A Macedo; Roberto A S Luz; José M Moita Neto; Ubirajara P Rodrigues Filho; Welter Cantanhêde
Journal:  Int J Mol Sci       Date:  2015-06-29       Impact factor: 5.923

3.  Methyl-β-cyclodextrin Inclusion Complex with β-Caryophyllene: Preparation, Characterization, and Improvement of Pharmacological Activities.

Authors:  Pauline S Santos; Luan K M Souza; Thiago S L Araújo; Jand Venes R Medeiros; Sandra C C Nunes; Rui A Carvalho; Alberto C C Pais; Francisco J B Veiga; Lívio C C Nunes; Ana Figueiras
Journal:  ACS Omega       Date:  2017-12-18

4.  Formulation and Evaluation of Supramolecular Food-Grade Piperine HP β CD and TPGS Complex: Dissolution, Physicochemical Characterization, Molecular Docking, In Vitro Antioxidant Activity, and Antimicrobial Assessment.

Authors:  Syed Sarim Imam; Sultan Alshehri; Talal Abdullah Alzahrani; Afzal Hussain; Mohammad A Altamimi
Journal:  Molecules       Date:  2020-10-14       Impact factor: 4.411

5.  Construction of a water-soluble and photostable rubropunctatin/β-cyclodextrin drug carrier.

Authors:  Zhenzhen Ren; Yanan Xu; Zhenxin Lu; Zhenzhen Wang; Chengqun Chen; Yanghao Guo; Xianai Shi; Feng Li; Jianmin Yang; Yunquan Zheng
Journal:  RSC Adv       Date:  2019-04-11       Impact factor: 4.036

6.  Polyvinylpyrrolidone K-30-Based Crosslinked Fast Swelling Nanogels: An Impeccable Approach for Drug's Solubility Improvement.

Authors:  Muhammad Usman Minhas; Kifayat Ullah Khan; Muhammad Sarfraz; Syed Faisal Badshah; Abubakar Munir; Kashif Barkat; Abdul Basit; Mosab Arafat
Journal:  Biomed Res Int       Date:  2022-08-26       Impact factor: 3.246

7.  Modified β-cyclodextrin inclusion complex to improve the physicochemical properties of albendazole. complete in vitro evaluation and characterization.

Authors:  Agustina García; Darío Leonardi; Mario Oscar Salazar; María Celina Lamas
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240

8.  Design of olanzapine/lutrol solid dispersions of improved stability and performances.

Authors:  Cristina Cavallari; Adamo Fini; Giancarlo Ceschel
Journal:  Pharmaceutics       Date:  2013-10-25       Impact factor: 6.321

Review 9.  Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations.

Authors:  Yana Zorkina; Olga Abramova; Valeriya Ushakova; Anna Morozova; Eugene Zubkov; Marat Valikhov; Pavel Melnikov; Alexander Majouga; Vladimir Chekhonin
Journal:  Molecules       Date:  2020-11-13       Impact factor: 4.411

10.  Formulation of Genistein-HP β Cyclodextrin-Poloxamer 188 Ternary Inclusion Complex: Solubility to Cytotoxicity Assessment.

Authors:  Ameeduzzafar Zafar; Nabil K Alruwaili; Syed Sarim Imam; Omar Awad Alsaidan; Faisal K Alkholifi; Khalid Saad Alharbi; Ehab M Mostafa; Abdullah S Alanazi; Sadaf Jamal Gilani; Arafa Musa; Sultan Alshehri; Alenazy Rawaf; Ali Alquraini
Journal:  Pharmaceutics       Date:  2021-11-24       Impact factor: 6.525

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.